Hot Features
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (... Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -25 | -1.49253731343 | 1675 | 1700 | 1557.5 | 6303 | 1666.90492812 | DE |
| 4 | -50 | -2.94117647059 | 1700 | 1725 | 1557.5 | 9494 | 1678.16744276 | DE |
| 12 | 200 | 13.7931034483 | 1450 | 1900 | 1350 | 11871 | 1632.97246649 | DE |
| 26 | -200 | -10.8108108108 | 1850 | 2012.5 | 1350 | 9752 | 1670.04573534 | DE |
| 52 | -1100 | -40 | 2750 | 3020 | 1350 | 10293 | 1990.25072116 | DE |
| 156 | -2100 | -56 | 3750 | 5060 | 1350 | 7929 | 2953.65878511 | DE |
| 260 | -2400 | -59.2592592593 | 4050 | 5060 | 1350 | 7183 | 3178.24903869 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.